Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Rheumatoid Arthritis

Free Subscription Articles published in PLoS One Retrieve available abstracts of 126 articles: HTML format

Single Articles

January 2024
1. HAI BB, Anh TL, Thi Thu PN, Van HN, et al
   Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study.
   PLoS One. 2024;19:e0295048.
   PubMed     Abstract available
   
   
   
2. MOMOSE T, Nakano M, Nakamura Y, Maeda T, et al
   Incidence and preventive treatment for deep vein thrombosis with our own preventive protocol in total hip and knee arthroplasty.
   PLoS One. 2024;19:e0293821.
   PubMed     Abstract available
   
   
   
3. WU L, Wang Q, Gao QC, Shi GX, et al
   Potential mechanisms and drug prediction of Rheumatoid Arthritis and primary Sjogren's Syndrome: A public databases-based study.
   PLoS One. 2024;19:e0298447.
   PubMed     Abstract available
   
   
   
4. LIU Z, Shao Y, Duan X
   Genetic link between primary biliary cholangitis and connective tissue diseases in European populations: A two-sample Mendelian randomization study.
   PLoS One. 2024;19:e0298225.
   PubMed     Abstract available
   
   
   
5. BERGMANS B, Jessurun N, van Lint J, Murk JL, et al
   Burden of non-serious infections during biological use for rheumatoid arthritis.
   PLoS One. 2024;19:e0296821.
   PubMed     Abstract available
   
   
   
6. DE ARAUJO BMM, de Miranda BM, Kowaltschuk TC, Goncalves FM, et al
   Impact of chronic diseases on the periapical health of endodontically treated teeth: A systematic review and meta-analysis.
   PLoS One. 2024;19:e0297020.
   PubMed     Abstract available
   
   
   
7. HUANG Z, Cui T, Yao J, Wu Y, et al
   Potential association of genetically predicted lipid and lipid-modifying drugs with rheumatoid arthritis: A Mendelian randomization study.
   PLoS One. 2024;19:e0298629.
   PubMed     Abstract available
   
   
   
8. MORI S, Ueki Y, Hasegawa M, Nakamura K, et al
   Impact of combined pulmonary fibrosis and emphysema on lung cancer risk and mortality in rheumatoid arthritis: A multicenter retrospective cohort study.
   PLoS One. 2024;19:e0298573.
   PubMed     Abstract available
   
   
   
9. TENG M, Wang J, Su X, Tian Y, et al
   Causal associations between rheumatoid arthritis, cataract and glaucoma in European and East Asian populations: A bidirectional two-sample mendelian randomization study.
   PLoS One. 2024;19:e0299192.
   PubMed     Abstract available
   
   
   
10. SHRESTHA DS, Manandhar S, Chalise BS, Rajbhandari SK, et al
    Symptoms 6 months following SARS-CoV-2 infection in Nepali women.
    PLoS One. 2024;19:e0299141.
    PubMed     Abstract available
    
    
    
11. SAKASHITA E, Nagatani K, Endo H, Minota S, et al
    Biomarker combination predicting imminent relapse after discontinuation of biological drugs in patients with rheumatoid arthritis in remission.
    PLoS One. 2024;19:e0299450.
    PubMed     Abstract available
    
    
    
12. DUDEK G, Sakowski S, Brzezinska O, Sarnik J, et al
    Machine learning-based prediction of rheumatoid arthritis with development of ACPA autoantibodies in the presence of non-HLA genes polymorphisms.
    PLoS One. 2024;19:e0300717.
    PubMed     Abstract available
    
    
    
13. ZHANG Z, Chen Y, Fu X, Chen L, et al
    Identification of PPARG as key gene to link coronary atherosclerosis disease and rheumatoid arthritis via microarray data analysis.
    PLoS One. 2024;19:e0300022.
    PubMed     Abstract available
    
    
    
14. CAI X, Jin Z, Zhang S, Liu J, et al
    Sjogren's syndrome and Parkinson's Disease: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298778.
    PubMed     Abstract available
    
    
    January 2023
15. GALINDO-DONAIRE JR, Hernandez-Molina G, Fresan Orellana A, Contreras-Yanez I, et al
    The role of personality traits on self-medicated cannabis in rheumatoid arthritis patients: A multivariable analysis.
    PLoS One. 2023;18:e0280219.
    PubMed     Abstract available
    
    
    
16. SONG YJ, Cho SK, Kim H, Kim HW, et al
    Factors associated with selection of targeted therapy in patients with rheumatoid arthritis.
    PLoS One. 2023;18:e0280234.
    PubMed     Abstract available
    
    
    
17. YANG S, Min HK, Park JS, Na HS, et al
    A green-lipped mussel prevents rheumatoid arthritis via regulation of inflammatory response and osteoclastogenesis.
    PLoS One. 2023;18:e0280601.
    PubMed     Abstract available
    
    
    
18. SANTO RCDE, Baker JF, Dos Santos LP, Silva JMS, et al
    Changes in physical function over time in rheumatoid arthritis patients: A cohort study.
    PLoS One. 2023;18:e0280846.
    PubMed     Abstract available
    
    
    
19. CONIGLIARO P, D'Antonio A, D'Erme L, Lavinia Fonti G, et al
    Failure and multiple failure for disease modifying antirheumatic drugs in rheumatoid arthritis: Real-life evidence from a tertiary referral center in Italy.
    PLoS One. 2023;18:e0281213.
    PubMed     Abstract available
    
    
    
20. HA SJ, Park SJ, Lee B, Moon H, et al
    Clinical outcomes of patients with rheumatoid arthritis who underwent percutaneous coronary intervention: A Korean nationwide cohort study.
    PLoS One. 2023;18:e0281067.
    PubMed     Abstract available
    
    
    
21. IZUMI K, Suzuki K, Hashimoto M, Endoh T, et al
    Detecting hand joint ankylosis and subluxation in radiographic images using deep learning: A step in the development of an automatic radiographic scoring system for joint destruction.
    PLoS One. 2023;18:e0281088.
    PubMed     Abstract available
    
    
    
22. NGUYEN THP, Fagerland MW, Hollan I, Whist JE, et al
    High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis.
    PLoS One. 2023;18:e0281155.
    PubMed     Abstract available
    
    
    
23. NAKAMURA H, Tanaka T, Ji Y, Zheng C, et al
    Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjogren's disease.
    PLoS One. 2023;18:e0282227.
    PubMed     Abstract available
    
    
    
24. AKASAKA D, Iguchi S, Kaneko R, Yoshiga Y, et al
    Novel Bruton's tyrosine kinase inhibitor TAS5315 suppresses the progression of inflammation and joint destruction in rodent collagen-induced arthritis.
    PLoS One. 2023;18:e0282117.
    PubMed     Abstract available
    
    
    
25. TALMON M, Percio M, Obeng JA, Ruffinatti FA, et al
    Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab.
    PLoS One. 2023;18:e0282564.
    PubMed     Abstract available
    
    
    
26. CHI C, Solomon O, Shiboski C, Taylor KE, et al
    Identification of Sjogren's syndrome patient subgroups by clustering of labial salivary gland DNA methylation profiles.
    PLoS One. 2023;18:e0281891.
    PubMed     Abstract available
    
    
    
27. LIN HL, Parkinson DH, Holman JC, Thompson WC, et al
    Modification of the structural stability of human serum albumin in rheumatoid arthritis.
    PLoS One. 2023;18:e0271008.
    PubMed     Abstract available
    
    
    
28. TYAGI N, Mehla K, Gupta D
    Deciphering novel common gene signatures for rheumatoid arthritis and systemic lupus erythematosus by integrative analysis of transcriptomic profiles.
    PLoS One. 2023;18:e0281637.
    PubMed     Abstract available
    
    
    
29. ZHAO X, Yang Y, Yue R, Su C, et al
    Potential causal association between leisure sedentary behaviors, physical activity and musculoskeletal health: A Mendelian randomization study.
    PLoS One. 2023;18:e0283014.
    PubMed     Abstract available
    
    
    
30. CIAFFI J, Ruscitti P, Di Cola I, Pavlych V, et al
    Whole body insulin sensitivity is increased in systemic sclerosis.
    PLoS One. 2023;18:e0283283.
    PubMed     Abstract available
    
    
    
31. GINEYTS E, Millet M, Borel O, Coutant F, et al
    Serum Col3-4: A new type III and IV collagen biochemical marker of synovial tissue turnover in patients with rheumatoid arthritis.
    PLoS One. 2023;18:e0282954.
    PubMed     Abstract available
    
    
    
32. VASILEIADIS GK, Sayols S, Zhao SS, Fatima T, et al
    Adipokines and risk of rheumatoid arthritis: A two-sample multivariable Mendelian randomisation study.
    PLoS One. 2023;18:e0286981.
    PubMed     Abstract available
    
    
    
33. ZHANG M, Yin J, Zhang X
    Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0286191.
    PubMed     Abstract available
    
    
    
34. KRISHNAMURTHY H, Yang Y, Song Q, Krishna K, et al
    Evaluation of renal markers in systemic autoimmune diseases.
    PLoS One. 2023;18:e0278441.
    PubMed     Abstract available
    
    
    
35. WEMAN L, Salo H, Kuusalo L, Huhtakangas J, et al
    Initial presentation of early rheumatoid arthritis.
    PLoS One. 2023;18:e0287707.
    PubMed     Abstract available
    
    
    
36. HUSSAIN MZ, Haris MS, Rizwan M, Ashraf NS, et al
    Deregulation of exosomal miRNAs in rheumatoid arthritis patients.
    PLoS One. 2023;18:e0289301.
    PubMed     Abstract available
    
    
    
37. FAQUETTI ML, Vallejo-Yague E, Cordtz R, Dreyer L, et al
    JAK-inhibitors and risk on serious viral infection, venous thromboembolism and cardiac events in patients with rheumatoid arthritis: A protocol for a prevalent new-user cohort study using the Danish nationwide DANBIO register.
    PLoS One. 2023;18:e0288757.
    PubMed     Abstract available
    
    
    
38. MESA LE, Lopez JG, Lopez Quiceno L, Barrios Arroyave F, et al
    Safety and efficacy of mesenchymal stem cells therapy in the treatment of rheumatoid arthritis disease: A systematic review and meta-analysis of clinical trials.
    PLoS One. 2023;18:e0284828.
    PubMed     Abstract available
    
    
    
39. FELIX GOMEZ GG, Hugenberg ST, Zunt S, Patel JS, et al
    Characterizing clinical findings of Sjogren's Disease patients in community practices using matched electronic dental-health record data.
    PLoS One. 2023;18:e0289335.
    PubMed     Abstract available
    
    
    
40. CHAPLIN H, Bosworth A, Simpson C, Wilkins K, et al
    Refractory inflammatory arthritis definition and model generated through patient and multi-disciplinary professional modified Delphi process.
    PLoS One. 2023;18:e0289760.
    PubMed     Abstract available
    
    
    
41. MUMTAZ T, Tahir A, Tariq MA, Iqbal MA, et al
    Comparative analysis of multiorgan toxicity induced by long term use of disease modifying anti-rheumatic drugs.
    PLoS One. 2023;18:e0290668.
    PubMed     Abstract available
    
    
    
42. UMEMOTO A, Ito H, Azukizawa M, Murata K, et al
    How do symptoms of each joint contribute to global pain, disease activity and functional disability in rheumatoid arthritis?-A comprehensive association study using a large cohort.
    PLoS One. 2023;18:e0285227.
    PubMed     Abstract available
    
    
    
43. YAGINUMA H, Saito Y, Sato T, Yamashita D, et al
    Clinical characteristics and outcomes of patients with chronic systemic inflammatory disease in acute myocardial infarction.
    PLoS One. 2023;18:e0289794.
    PubMed     Abstract available
    
    
    
44. MCCREADY JL, McCarty K, Deary V, Collins TL, et al
    A qualitative exploration of internet forum discussions surrounding female sexual function for individuals with Sjogren's syndrome.
    PLoS One. 2023;18:e0291422.
    PubMed     Abstract available
    
    
    
45. LOURINHO I, Sousa T, Jardim R, Pinto AC, et al
    Effects of low-level laser therapy in adults with rheumatoid arthritis: A systematic review and meta-analysis of controlled trials.
    PLoS One. 2023;18:e0291345.
    PubMed     Abstract available
    
    
    
46. YAMAGUCHI S, Kimura S, Watanabe S, Mikami Y, et al
    Internet search analysis on the treatment of rheumatoid arthritis: What do people ask and read online?
    PLoS One. 2023;18:e0285869.
    PubMed     Abstract available
    
    
    
47. ALI Y, Kausar M, Farooq M, Farooqi N, et al
    Association of IL-17F rs2397084 (E126G), rs11465553 (V155I) and rs763780 (H161R) variants with rheumatoid arthritis and their effects on the stability of protein.
    PLoS One. 2023;18:e0285874.
    PubMed     Abstract available
    
    
    
48. BESSA EJC, Ribeiro FMC, Rodrigues RS, Henrique da Costa C, et al
    Association between clinical, serological, functional and radiological findings and ventilatory distribution heterogeneity in patients with rheumatoid arthritis.
    PLoS One. 2023;18:e0291659.
    PubMed     Abstract available
    
    
    
49. ZENG HL, Qiu Q, Fu TX, Deng AP, et al
    Development and optimization of sustained release triptolide microspheres.
    PLoS One. 2023;18:e0292861.
    PubMed     Abstract available
    
    
    
50. HUGHES-AUSTIN JM, Katz R, Majka DS, Criqui MH, et al
    Serum reactivity to citrullinated protein/peptide antigens and left ventricular structure and function in the Multi-Ethnic Study of Atherosclerosis (MESA).
    PLoS One. 2023;18:e0291967.
    PubMed     Abstract available
    
    
    
51. PORTES J, Santo RCE, Xavier RM, Brenol CV, et al
    Funcionality assessed by the core set of the international classification of functionality and health for rheumatoid arthritis: A cohort study.
    PLoS One. 2023;18:e0286342.
    PubMed     Abstract available
    
    
    
52. MILADI S, Makhlouf Y, Boussaa H, Zakraoui L, et al
    Effect of bariatric and metabolic surgery on rheumatoid arthritis outcomes: A systematic review.
    PLoS One. 2023;18:e0294277.
    PubMed     Abstract available
    
    
    
53. XU S, Zhang Q, Zhou J
    The mediting role of psychological resilience on the negative effect of pain in patients with rheumatoid arthritis: A cross-sectional study.
    PLoS One. 2023;18:e0295255.
    PubMed     Abstract available
    
    
    
54. MUNIR A, Khan S, Khan S, Attaullah S, et al
    Frequency and association of Epstein-Barr Virus genotype in rheumatoid arthritis patients of Khyber Pakhtunkhwa, Pakistan.
    PLoS One. 2023;18:e0295124.
    PubMed     Abstract available
    
    
    January 2022
55. YANAGISAWA S, Nagasaki K, Chea C, Ando T, et al
    Oral administration of bovine lactoferrin suppresses the progression of rheumatoid arthritis in an SKG mouse model.
    PLoS One. 2022;17:e0263254.
    PubMed     Abstract available
    
    
    
56. LIU C, Fan F, Zhong L, Su J, et al
    Elucidating the material basis and potential mechanisms of Ershiwuwei Lvxue Pill acting on rheumatoid arthritis by UPLC-Q-TOF/MS and network pharmacology.
    PLoS One. 2022;17:e0262469.
    PubMed     Abstract available
    
    
    
57. NGUYEN THP, Hokstad I, Fagerland MW, Mollnes TE, et al
    Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis.
    PLoS One. 2022;17:e0264628.
    PubMed     Abstract available
    
    
    
58. HU J, Zhao L, Li N, Yang Y, et al
    Investigation of the active ingredients and pharmacological mechanisms of Porana sinensis Hemsl. Against rheumatoid arthritis using network pharmacology and experimental validation.
    PLoS One. 2022;17:e0264786.
    PubMed     Abstract available
    
    
    
59. YASUDA T, Tahara K, Sawada T
    Detection of salivary citrullinated cytokeratin 13 in healthy individuals and patients with rheumatoid arthritis by proteomics analysis.
    PLoS One. 2022;17:e0265687.
    PubMed     Abstract available
    
    
    
60. WHITE IR, Kleinstein SE, Praet C, Chamberlain C, et al
    A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population.
    PLoS One. 2022;17:e0261165.
    PubMed     Abstract available
    
    
    
61. SHIRAISHI K, Chiba K, Watanabe K, Oki N, et al
    Analysis of bone erosions in rheumatoid arthritis using HR-pQCT: Development of a measurement algorithm and assessment of longitudinal changes.
    PLoS One. 2022;17:e0265833.
    PubMed     Abstract available
    
    
    
62. NAM SH, Ahn SM, Oh JS, Hong S, et al
    Macrophage activation syndrome in rheumatic disease: Clinical characteristics and prognosis of 20 adult patients.
    PLoS One. 2022;17:e0267715.
    PubMed     Abstract available
    
    
    
63. GENC D, Bulut O, Gunaydin B, Goksu M, et al
    Dental follicle mesenchymal stem cells ameliorated glandular dysfunction in Sjogren's syndrome murine model.
    PLoS One. 2022;17:e0266137.
    PubMed     Abstract available
    
    
    
64. GHOURI M, Ismail M, Zaidi SA, Rehman S, et al
    Multi-locus SNP analyses of interleukin 1 receptor associated kinases 2 gene polymorphisms with the susceptibility to rheumatoid arthritis.
    PLoS One. 2022;17:e0268496.
    PubMed     Abstract available
    
    
    
65. DESSIE G
    Association of atherogenic indices with C-reactive protein and risk factors to assess cardiovascular risk in rheumatoid arthritis patient at Tikur Anbessa Specialized Hospital, Addis Ababa.
    PLoS One. 2022;17:e0269431.
    PubMed     Abstract available
    
    
    
66. LI Z, Mu Y, Guo C, You X, et al
    Analysis of the saliva metabolic signature in patients with primary Sjogren's syndrome.
    PLoS One. 2022;17:e0269275.
    PubMed     Abstract available
    
    
    
67. MORI S, Okada A, Koga T, Ueki Y, et al
    Long-term outcomes after discontinuing biological drugs and tofacitinib in patients with rheumatoid arthritis: A prospective cohort study.
    PLoS One. 2022;17:e0270391.
    PubMed     Abstract available
    
    
    
68. MIKAMI S, Miura Y, Kondo S, Sakai K, et al
    Nintedanib induces gene expression changes in the lung of induced-rheumatoid arthritis-associated interstitial lung disease mice.
    PLoS One. 2022;17:e0270056.
    PubMed     Abstract available
    
    
    
69. GONI M, Basu N, Murray AD, Waiter GD, et al
    Brain predictors of fatigue in rheumatoid arthritis: A machine learning study.
    PLoS One. 2022;17:e0269952.
    PubMed     Abstract available
    
    
    
70. WAKI D, Tamai H, Yokochi R, Kido T, et al
    Effects of anti-SSA antibodies on the response to methotrexate in rheumatoid arthritis: A retrospective multicenter observational study.
    PLoS One. 2022;17:e0271921.
    PubMed     Abstract available
    
    
    
71. MOVAHEDI M, Cesta A, Li X, Bombardier C, et al
    Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort.
    PLoS One. 2022;17:e0274264.
    PubMed     Abstract available
    
    
    
72. TEMMOKU J, Miyata M, Suzuki E, Sumichika Y, et al
    Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis.
    PLoS One. 2022;17:e0274775.
    PubMed     Abstract available
    
    
    
73. SANTOS IA, Donizeti Ribeiro de Oliveira R, Couto Luna Almeida S, Vargas-Santos AB, et al
    Comparison of rheumatoid arthritis composite disease activity indices and residual activity in a Brazilian multicenter study- REAL study.
    PLoS One. 2022;17:e0273789.
    PubMed     Abstract available
    
    
    
74. SCRIVO R, Molteni E, Castellani C, Altobelli A, et al
    Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors?
    PLoS One. 2022;17:e0275329.
    PubMed     Abstract available
    
    
    
75. VALLEJO-YAGUE E, Pfund JN, Burkard T, Clair C, et al
    Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort.
    PLoS One. 2022;17:e0275026.
    PubMed     Abstract available
    
    
    
76. REITER MP, Ward SH, Perry B, Mann A, et al
    Intra-articular injection of epigallocatechin (EGCG) crosslinks and alters biomechanical properties of articular cartilage, a study via nanoindentation.
    PLoS One. 2022;17:e0276626.
    PubMed     Abstract available
    
    
    
77. JUNG N, Park S, Kong T, Park H, et al
    LC-MS/MS-based serum proteomics reveals a distinctive signature in a rheumatoid arthritis mouse model after treatment with mesenchymal stem cells.
    PLoS One. 2022;17:e0277218.
    PubMed     Abstract available
    
    
    
78. TANAKA E, Inoue E, Shoji A, Nilsson J, et al
    Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data.
    PLoS One. 2022;17:e0277566.
    PubMed     Abstract available
    
    
    
79. LI Y, Li Z, Sun W, Wang M, et al
    Characteristics of gut microbiota in patients with primary Sjogren's syndrome in Northern China.
    PLoS One. 2022;17:e0277270.
    PubMed     Abstract available
    
    
    
80. DISSANAYAKE K, Jayasinghe C, Wanigasekara P, Dissanayake J, et al
    Validity of clinical disease activity index (CDAI) to evaluate the disease activity of rheumatoid arthritis patients in Sri Lanka: A prospective follow up study based on newly diagnosed patients.
    PLoS One. 2022;17:e0278285.
    PubMed     Abstract available
    
    
    
81. LOPEZ-OLIVO MA, Sharma G, Singh G, James J, et al
    A systematic review with meta-analysis of the effects of smoking cessation strategies in patients with rheumatoid arthritis.
    PLoS One. 2022;17:e0279065.
    PubMed     Abstract available
    
    
    
82. SCHMIDT NS, Voss A, Nilsson AC, Terslev L, et al
    Salivary gland ultrasound is associated with the presence of autoantibodies in patients with Sjogren's syndrome: A Danish single-centre study.
    PLoS One. 2022;17:e0265057.
    PubMed     Abstract available
    
    
    
83. NARDINI C, Candelise L, Turrini M, Addimanda O, et al
    Semi-automated socio-anthropologic analysis of the medical discourse on rheumatoid arthritis: Potential impact on public health.
    PLoS One. 2022;17:e0279632.
    PubMed     Abstract available
    
    
    January 2021
84. PAGLIA MDG, Silva MT, Lopes LC, Barberato-Filho S, et al
    Use of corticoids and non-steroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review and network meta-analysis.
    PLoS One. 2021;16:e0248866.
    PubMed     Abstract available
    
    
    
85. KUR-ZALEWSKA J, Kisiel B, Kania-Pudlo M, Tlustochowicz M, et al
    A dose-dependent beneficial effect of methotrexate on the risk of interstitial lung disease in rheumatoid arthritis patients.
    PLoS One. 2021;16:e0250339.
    PubMed     Abstract available
    
    
    
86. DONNELLY S, Wilson AG, Mannan H, Dix C, et al
    Correction: (In)Visible illness: A photovoice study of the lived experience of self-managing rheumatoid arthritis.
    PLoS One. 2021;16:e0250451.
    PubMed     Abstract available
    
    
    
87. LIN CT, Huang WN, Tsai WC, Chen JP, et al
    Predictors of drug survival for biologic and targeted synthetic DMARDs in rheumatoid arthritis: Analysis from the TRA Clinical Electronic Registry.
    PLoS One. 2021;16:e0250877.
    PubMed     Abstract available
    
    
    
88. TATANGELO M, Tomlinson G, Paterson JM, Keystone E, et al
    Health care costs of rheumatoid arthritis: A longitudinal population study.
    PLoS One. 2021;16:e0251334.
    PubMed     Abstract available
    
    
    
89. KATO M, Ikeda K, Sugiyama T, Tanaka S, et al
    Associations of ultrasound-based inflammation patterns with peripheral innate lymphoid cell populations, serum cytokines/chemokines, and treatment response to methotrexate in rheumatoid arthritis and spondyloarthritis.
    PLoS One. 2021;16:e0252116.
    PubMed     Abstract available
    
    
    
90. LEE DH, Sheen SH, Lee DG, Jang JW, et al
    Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.
    PLoS One. 2021;16:e0251851.
    PubMed     Abstract available
    
    
    
91. MATSUMOTO Y, Takahashi K, Sugioka Y, Inui K, et al
    Double-blinded randomized controlled trial to reveal the effects of Brazilian propolis intake on rheumatoid arthritis disease activity index; BeeDAI.
    PLoS One. 2021;16:e0252357.
    PubMed     Abstract available
    
    
    
92. FRAENKEL L, Wei Z, Ramsey C, Wiedmeyer C, et al
    OPEX: Development of a novel overall patient experience measure to facilitate interpretation of comparison effectiveness studies.
    PLoS One. 2021;16:e0245598.
    PubMed     Abstract available
    
    
    
93. NIK-AZIS NM, Mohd N, Mohd Fadzilah F, Mohamed Haflah NH, et al
    Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study.
    PLoS One. 2021;16:e0252859.
    PubMed     Abstract available
    
    
    
94. REPAC J, Mandic M, Lunic T, Bozic B, et al
    Mining the capacity of human-associated microorganisms to trigger rheumatoid arthritis-A systematic immunoinformatics analysis of T cell epitopes.
    PLoS One. 2021;16:e0253918.
    PubMed     Abstract available
    
    
    
95. KALWEIT M, Walker UA, Finckh A, Muller R, et al
    Personalized prediction of disease activity in patients with rheumatoid arthritis using an adaptive deep neural network.
    PLoS One. 2021;16:e0252289.
    PubMed     Abstract available
    
    
    
96. DEYAB G, Reine TM, Vuong TT, Jenssen T, et al
    Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
    PLoS One. 2021;16:e0253247.
    PubMed     Abstract available
    
    
    
97. TAKESHITA A, Nishida K, Yoshida A, Nasu Y, et al
    RANKL expression in chondrocytes and its promotion by lymphotoxin-alpha in the course of cartilage destruction during rheumatoid arthritis.
    PLoS One. 2021;16:e0254268.
    PubMed     Abstract available
    
    
    
98. JAYARAM M, Wang C, Wang L, Chung KC, et al
    Validating the Michigan Hand Outcomes Questionnaire in patients with rheumatoid arthritis using Rasch analysis.
    PLoS One. 2021;16:e0254984.
    PubMed     Abstract available
    
    
    
99. MOON SJ, Jhun J, Ryu J, Kwon JY, et al
    The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines.
    PLoS One. 2021;16:e0245986.
    PubMed     Abstract available
    
    
    
100. RASKER JJ, Wolfe F, Klaver-Krol EG, Zwarts MJ, et al
     The relation of fibromyalgia and fibromyalgia symptoms to self-reported seizures.
     PLoS One. 2021;16:e0246051.
     PubMed     Abstract available
     
     
     
101. MINAMINO H, Katsushima M, Hashimoto M, Fujita Y, et al
     Influence of dietary habits on depression among patients with rheumatoid arthritis: A cross-sectional study using KURAMA cohort database.
     PLoS One. 2021;16:e0255526.
     PubMed     Abstract available
     
     
     
102. LIN PH, Yu SF, Chen JF, Chen YC, et al
     Risk factor analysis of fragility fractures in rheumatoid arthritis: A 3-year longitudinal, real-world, observational, cohort study.
     PLoS One. 2021;16:e0255542.
     PubMed     Abstract available
     
     
     
103. KUMAR SK, Arya S, Singh A, Misra R, et al
     Patterns of T and B cell responses to Mycobacterium tuberculosis membrane-associated antigens and their relationship with disease activity in rheumatoid arthritis patients with latent tuberculosis infection.
     PLoS One. 2021;16:e0255639.
     PubMed     Abstract available
     
     
     
104. TRIKHA R, Greig D, Sekimura T, Cevallos N, et al
     Active rheumatoid arthritis in a mouse model is not an independent risk factor for periprosthetic joint infection.
     PLoS One. 2021;16:e0250910.
     PubMed     Abstract available
     
     
     
105. GONZALEZ-PONCE F, Gamez-Nava JI, Perez-Guerrero EE, Saldana-Cruz AM, et al
     Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis.
     PLoS One. 2021;16:e0255854.
     PubMed     Abstract available
     
     
     
106. CHI C, Taylor KE, Quach H, Quach D, et al
     Hypomethylation mediates genetic association with the major histocompatibility complex genes in Sjogren's syndrome.
     PLoS One. 2021;16:e0248429.
     PubMed     Abstract available
     
     
     
107. KHALED SAA, Mahmoud HFF
     Platelet indices parameters in the new disease activity score of rheumatoid arthritis with ankle involvement: A comparative analytic study.
     PLoS One. 2021;16:e0257200.
     PubMed     Abstract available
     
     
     
108. KARYDIS A, Sandal I, Luo J, Prislovsky A, et al
     Influence of the shared epitope on the elicitation of experimental autoimmune arthritis biomarkers.
     PLoS One. 2021;16:e0250177.
     PubMed     Abstract available
     
     
     
109. DIAZ-GALLO LM, Brynedal B, Westerlind H, Sandberg R, et al
     Understanding interactions between risk factors, and assessing the utility of the additive and multiplicative models through simulations.
     PLoS One. 2021;16:e0250282.
     PubMed     Abstract available
     
     
     
110. TURESSON WADELL A, Barebring L, Hulander E, Gjertsson I, et al
     Effects on health-related quality of life in the randomized, controlled crossover trial ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis).
     PLoS One. 2021;16:e0258716.
     PubMed     Abstract available
     
     
     
111. NAKAE K, Masui S, Yonezawa A, Hashimoto M, et al
     Potential application of measuring serum infliximab levels in rheumatoid arthritis management: A retrospective study based on KURAMA cohort data.
     PLoS One. 2021;16:e0258601.
     PubMed     Abstract available
     
     
     
112. LIU W, Ma W, Liu H, Li C, et al
     Stroke risk in arthritis: A systematic review and meta-analysis of cohort studies.
     PLoS One. 2021;16:e0248564.
     PubMed     Abstract available
     
     
     
113. SHIBATA K, Yoshimura A, Ikeuchi S, Ishii M, et al
     Effectiveness of drug safety measures for reducing the incidence of adverse drug reactions: Post-hoc analysis of data from all-case surveillance of iguratimod using generalized estimating equations.
     PLoS One. 2021;16:e0253513.
     PubMed     Abstract available
     
     
     
114. DOS SANTOS LP, Santo RCDE, Ramis TR, Portes JKS, et al
     The effects of resistance training with blood flow restriction on muscle strength, muscle hypertrophy and functionality in patients with osteoarthritis and rheumatoid arthritis: A systematic review with meta-analysis.
     PLoS One. 2021;16:e0259574.
     PubMed     Abstract available
     
     
     
115. MATSUMOTO H, Fujita Y, Asano T, Matsuoka N, et al
     Association between inflammatory cytokines and immune-checkpoint molecule in rheumatoid arthritis.
     PLoS One. 2021;16:e0260254.
     PubMed     Abstract available
     
     
     
116. KAWAHITO Y, Takakubo Y, Morinobu A, Matsubara N, et al
     Patient satisfaction, preferences, expectations, characteristics, and impact of suboptimal control of rheumatoid arthritis: A subgroup analysis of Japanese patients from a large international cohort study (SENSE).
     PLoS One. 2021;16:e0259389.
     PubMed     Abstract available
     
     
     
117. GVOZDJAKOVA A, Sumbalova Z, Kucharska J, Szamosova M, et al
     Platelet mitochondrial respiration and coenzyme Q10 could be used as new diagnostic strategy for mitochondrial dysfunction in rheumatoid diseases.
     PLoS One. 2021;16:e0256135.
     PubMed     Abstract available
     
     
     
118. SEMBLER-MOLLER ML, Belstrom D, Locht H, Pedersen AML, et al
     Combined serum anti-SSA/Ro and salivary TRIM29 reveals promising high diagnostic accuracy in patients with primary Sjogren's syndrome.
     PLoS One. 2021;16:e0258428.
     PubMed     Abstract available
     
     
     
119. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
     Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
     PLoS One. 2021;16:e0249809.
     PubMed     Abstract available
     
     
     
120. FUJITA Y, Yago T, Asano T, Matsumoto H, et al
     Clinical relevance for circulating cold-inducible RNA-binding protein (CIRP) in patients with adult-onset Still's disease.
     PLoS One. 2021;16:e0255493.
     PubMed     Abstract available
     
     
     
121. NOH ASM, Chuan TD, Khir NAM, Zin AAM, et al
     Effects of different doses of complete Freund's adjuvant on nociceptive behaviour and inflammatory parameters in polyarthritic rat model mimicking rheumatoid arthritis.
     PLoS One. 2021;16:e0260423.
     PubMed     Abstract available
     
     
     
122. O'BRIEN P, Conley B, Bunzli S, Bullen J, et al
     Staying moving, staying strong: Protocol for developing culturally appropriate information for Aboriginal people with osteoarthritis, rheumatoid arthritis, lupus and gout.
     PLoS One. 2021;16:e0261670.
     PubMed     Abstract available
     
     
     
123. CHENG BR, Chen JQ, Zhang XW, Gao QY, et al
     Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis.
     PLoS One. 2021;16:e0261239.
     PubMed     Abstract available
     
     
     
124. RUDD PA, Lim EXY, Stapledon CJM, Krishnan R, et al
     Pentosan polysulfate sodium prevents functional decline in chikungunya infected mice by modulating growth factor signalling and lymphocyte activation.
     PLoS One. 2021;16:e0255125.
     PubMed     Abstract available
     
     
     
125. MIN HK, Kim SH, Park Y, Lee KA, et al
     Ultrasonographic characteristics of major salivary glands in anti-centromere antibody-positive primary Sjogren's syndrome.
     PLoS One. 2021;16:e0259519.
     PubMed     Abstract available
     
     
     
126. CUI D, Mathews P, Li G, VanCourt S, et al
     Outcomes of Sjogren's versus non-Sjogren's related dry eye in a longitudinal, tertiary clinic-based sample.
     PLoS One. 2021;16:e0261241.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.